ARS Investment Partners, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 91 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2017. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
ARS Investment Partners, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$6,937,000
+909.8%
45,892
+872.9%
0.95%
+914.9%
Q2 2022$687,000
-98.7%
4,717
-98.9%
0.09%
-98.1%
Q1 2022$51,356,000
-19.6%
433,124
-6.5%
4.95%
-15.6%
Q4 2021$63,860,000
-1.5%
463,392
-0.7%
5.86%
-9.6%
Q3 2021$64,825,000
+19.6%
466,668
-16.4%
6.49%
+17.4%
Q2 2021$54,198,000
+41.2%
558,286
-0.6%
5.52%
+23.9%
Q1 2021$38,375,000
-20.0%
561,442
+0.4%
4.46%
-24.5%
Q4 2020$47,949,000
+31.8%
559,437
-0.0%
5.90%
+3.2%
Q3 2020$36,378,000
-17.8%
559,574
-7.5%
5.72%
-31.3%
Q2 2020$44,249,000
+115.6%
605,242
+0.4%
8.33%
+68.1%
Q1 2020$20,521,000
-35.6%
603,036
+3.0%
4.95%
-7.5%
Q4 2019$31,863,000
+33.8%
585,289
+2.5%
5.36%
+25.2%
Q3 2019$23,814,000
-0.1%
570,808
+4.9%
4.28%
+6.8%
Q2 2019$23,832,000
-0.2%
544,223
+17.3%
4.01%
-7.4%
Q1 2019$23,889,000
+60.2%
464,127
+15.1%
4.32%
+37.0%
Q4 2018$14,913,000
-4.4%
403,271
-3.0%
3.16%
+30.6%
Q3 2018$15,604,000
+1.3%
415,555
+6.6%
2.42%
-1.7%
Q2 2018$15,408,000
+129.8%
389,889
+49.8%
2.46%
+199.5%
Q1 2018$6,704,000
+133.8%
260,255
+144.8%
0.82%
+136.6%
Q4 2017$2,868,000106,3120.35%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2017
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders